TRI-POINT LIQUIMMUNE LIQUID ASSAYED IMMUNOASSAY CONTROL

Drug Mixture Control Materials

MEDICAL ANALYSIS SYSTEMS, INC.

The following data is part of a premarket notification filed by Medical Analysis Systems, Inc. with the FDA for Tri-point Liquimmune Liquid Assayed Immunoassay Control.

Pre-market Notification Details

Device IDK954322
510k NumberK954322
Device Name:TRI-POINT LIQUIMMUNE LIQUID ASSAYED IMMUNOASSAY CONTROL
ClassificationDrug Mixture Control Materials
Applicant MEDICAL ANALYSIS SYSTEMS, INC. 542 FLYNN RD. Camarillo,  CA  93012 -8058
ContactKevin Kennan
CorrespondentKevin Kennan
MEDICAL ANALYSIS SYSTEMS, INC. 542 FLYNN RD. Camarillo,  CA  93012 -8058
Product CodeDIF  
CFR Regulation Number862.3280 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1995-09-15
Decision Date1995-10-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.